D-0855-2017 Class II Terminated

Recalled by Sato Pharmaceutical Inc. — Torrance, CA

Recall Details

Product Type
Drugs
Report Date
May 31, 2017
Initiation Date
February 16, 2017
Termination Date
March 13, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,790 bottles

Product Description

SATO CLEAR (naphazoline hydrochloride) Redness Reliever Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-044-01

Reason for Recall

Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Distribution Pattern

US: Hawaii, Guam, Saipan, SPI

Code Information

Lot #: WXWZ, Exp. March 2019; WXTS, Exp. October 2019